Category: ‘Ended Projects’

Finished projects

September 14, 2011 Posted by nikola

MEED_Projects1. Copernicus Contract CIPA CT 94-0152 Genetically Engineered Vaccines”; Project leader P. Capel 

1995-1998

2. NFSI – Bulgaria L 808 “Natural antibodies in healthy individuals”; Project leader T. Vassilev

1999-2002

3. HHMI – USA “Regulatory cells in Autoimmunity”; Project leader: T. Vassilev

2000-2004

4. Bulgarian-Hungarian international joint project “Selective suppression by a chimeric antibody of DNA-specific B cells in systemic lupus; Project leader: T. Vassilev

2003-2006

5. Taiwan-Bulgarian international joint project Mouse models of SLE ; Project leader T. Vassilev

2003-2005

6. NFSI – Bulgaria L1304/03 Selective suppression of anti-DNA antibodies producing cells in experimental models of Lupus using chimeric anti-CD32 antibodies; Project leader: A. Tchorbanov

2003-2006

7. NFSI – Bulgaria L1304/03 Selective suppression of anti-DNA antibodies producing cells in experimental models of Lupus using chimeric  anti-CD32 antibodies; Project leader A. Tchorbanov

2003-2006

8. NFSI – Bulgaria TXK 1611/06 “Development of biotechnology for production of biologically active compondns from Rapana thomasiana hemocyanin“; Project leader for IM-BAS A. Tchorbanov

2006-2010

9. Bulgarian-Hungarian international joint project “Selective suppression of DNA-specific B lymphocytes using engineered DNA chimeric molecules in human models of lupus; Project leader A. Tchorbanov

2007-2010

10. NFSI – Bulgaria VU 704/07 New approach for selective suppression of autoreactive B cells by a chimeric anti-CD35 antibody; Project leader for IM-BAS A. Tchorbanov

2007-2011

11. NFSI – Bulgaria TK 317/07 “Generation of gene-engineered chimeric DNA molecules by recombinant technologies for specific therapy of autoimmune diseases”; Project leader A. Tchorbanov

2007-2011

12. NFSI – Bulgaria VUH 11/07 “Creation of engineered chimeric molecules by protein nano-technology for therapy of autoimmune diseases”; Project leader for IM-BAS A. Tchorbanov

2007-2011

13. Institute of Microbiology – Military Academy – Sofia joint project Studying the developmental role of amyloid precursor protein and prion protein in chimeric brains; Project leader A. Michova. Project leader for IM-BAS A. Tchorbanov

2008-2009

14. NFSI – Bulgaria DO 312/08 “Suppression of allergen-specific B lymphocytes in humanized SCID mice using Chimeric protein-engineered antibodies”; Project leader for IM-BAS A. Tchorbanov

2008-2012

15. NFSI – Bulgaria DRNF 02/11 “Biologic response of neoplastic and auto-immune B-cells to chimeric protein-engineered antibodies: flow cytometry analysis of apoptosis using novel cyanine nucleic acid dyes”; Project leader P. Dimitrova; Project co-leader A. Tchorbanov

2009-2012

16. Bulgarian-Hungarian international joint project “Genetically engineered viral DNA vaccines; Project leader A. Tchorbanov

2010-2013

17. NFSI – Bulgaria DTK 02/78 “Antitumor activity of Gastropodan hemocyanins”; Project leader for IM-BAS A. Tchorbanov

2010-2014

18. NFSI – Bulgaria DTK 02/19 “DNA vaccines: Viral Antigen Targeting by Genetically Engineered Chimeric Molecules”; Project leader A. Tchorbanov

2010-2016

19. NFSI – Bulgaria DVU 10-250 “Functional elimination of autoreactive T cells by antibody therapy in murine and humanized SCID models of Systemic lupus erythematosus and Multiple sclerosis”; Project leader for IM-BAS A. Tchorbanov

2011-2017

20. ACIP – ACTIONS CONCERTEES INTERPASTEURIENNES. „Viral Antigen Targeting by Genetically Engineered Chimeric Molecules; Project leader A. Tchorbanov

2013-2015

21. Bulgarian-Hungarian international joint project “Functional suppression of autoreactive T cells in murine and humanized SCID models of SLE; Project leader A. Tchorbanov

2013-2015

22. NFSI – Bulgaria DFNI B-01/10 “Isolation, characterization and in vitro differentiation of ovarian stem cells”; Project leader P. Todorov; Project leader for IM-BAS A. Tchorbanov

2013-2014

23. BAS – Sofia University St. K. Ohridski joint project “Cell quiescence: Role of cell compartmentalization of the extracellular signal-regulated kinases (ERK); Project leader R. Pankov; Project leader for IM-BAS A. Tchorbanov

2014-2016

24. Taiwan-Bulgarian (BAS – Ministry of Science and Technology) international joined project “Study on the immune modulation of disease severity in humanized SCID murine model of immunological diseases; Project leader A. Tchorbanov

2015-2017

25. Program of BAS for young scientist support №293 „New approach for tumor inhibition by hemocyanin therapy in model of colorectal cancer”; Project leader A. Tchorbanov;

2016-2017

26. BAS-Neopharm Bulgaria Ltd joint project “Experimental C57B6 mouse model for test of probiotic activity and colonisation under SPF (Specific pathogen free) conditions; Project leader A. Tchorbanov

2015-2017

27. BAS-Medical University Pleven joint project “Investigation of the process of generating platelets’ derived microparticles (PMP) and the morphological changes under the action of platelet-activating and inhibiting factors in patients with deep venous thrombosis carriers of the G20210A PTM mutation”; Project leader R. Komsa-Penkova; Project leader for IM-BAS A. Tchorbanov.

2016-2017

28. BAS-Medical University Sofia joint project “Investigation of oogenesis quality in mice with experimentally induced systemic lupus; Project leader S. Delimitreva; Project leader for IM-BAS A. Tchorbanov.

2016-2017

29. Bulgarian-Egyptian (BAS – Academy of Scientific Research and Technology Scientific & Cultural Relations Sector) international joint project “Adoptive T cell therapy as a new approach for pancreatic cancer; Project leader A. Tchorbanov

2016-2018

30. Bulgarian-Italian (BAS – National Research Council) international joint project “A novel approach for cancer treatment by activated monocyte – derived macrophages”; Project leader A. Tchorbanov

2016-2019